New chemo spray targets stomach cancer spread
NCT ID NCT04956068
First seen May 17, 2026 · Last updated May 17, 2026
Summary
This early-stage study tests a method called PIPAC, which sprays chemotherapy directly into the abdomen as a fine mist. It aims to ease symptoms in people with advanced cancer that has spread to the lining of the belly and who cannot have surgery. The main goal is to see if the procedure is safe and feasible for 25 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL METASTASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Cancer Center Singapore
Singapore, 169690, Singapore
Conditions
Explore the condition pages connected to this study.